Toni Felís

[Toni Felís @ToniFs7]

@joanjubany Una abraçada gran Joan

[Toni Felís @ToniFs7]

@lacompetencia Autèntica mel!!! He escoltat aquest tall pel podcast com 10 cops! Sou molt grans!!

[La Competència @lacompetencia]

En Jep Cabestany recrea la baralla entre Tchouaméni i Valverde amb una IA.

[VERSIÓ RAC1 @versiorac1]

🍰Christian Escribà (@escriba1906) volia sorprendre Lamine… però Flick li va posar una condició inesperada

[Toni Felís @ToniFs7]

@kantinu Pell de gallina!

[Toni Felís @ToniFs7]

@joanjubany Una abraçada ben forta a la família Jubany!

[Pedro Rodrigues @PMRodrigues19]

‼️We are hiring ‼️

Looking for motivated postdoctoral researchers to work in:

#LiverCancer
#CCA
#HCC
#MASLD

🧪Translational research
💊Therapeutic targets
🩸Biomarkers
🐭Animal models

More info
👉🏼 https://t.co/8RSZPgnB5i

@biogipuzkoa @JesusMBanales

[Asociación Española para el Estudio del Hígado @AEEHLiver]

🗣️Auditorio lleno para oír la conferencia magiestral del catedrático y académico chileno @MarcoArreseMD: "‘Met-ALD, la intersección entre EHMet y EHAlc".
➡️Prevalencia del METALD: entre un 8-10% en la población general en el mundo.
➡️Hay falta de reporte de consumo de alcohol en pacientes
➡️El alcohol tiene influencia directa sobre los factores de riesgo cardiometabólico.
➡️Los pacientes que hacen 'binge-drinking' presentan hipertensión.
➡️El alcohol es un factor fibrogenico mas potente y hace que la enfermedad progrese más rápido.👌 #AEEH2025 #50CongresoAEEH

[Rubió Metabolomics @RubioOmics]

On #WorldCCADay, we want to support those impacted by #cholangiocarcinoma, a rare but aggressive cancer that often goes unnoticed.

Thanks to physicians, researchers & patient associations who fight #biliarytractcancer. It is worth the effort if it has a life-changing impact.

[Rubió Metabolomics @RubioOmics]

🌍 Rubió Metabolomics, prev. @OWLMetabolomics , attends the #LMN2025 the 14th of February at Gordon Museum of Pathology.
🔬 Leading in cutting-edge #Metabolomic solutions—from #Biomarkers to #ClinicalAdvancements.
💡 Book a meeting at [email protected]

#MASLD #MASH

[Rubió Metabolomics @RubioOmics]

Today begins a new era in Rubió Group.

In the #SumandoValores2024 Day, we have presented our new brand identity, a reflection of who we are and where we are going.

#SumandoValores2024 #LifeFeelsGood #WeAreRubió #Rebranding

[Javier Crespo @DrJavierCrespo]

El #MASEFScore revoluciona el diagnóstico no invasivo de MASH avanzado. ¿La mejor parte? Funciona igual de bien en pacientes bajo terapia con estatinas. ¡Un gran paso en la lucha contra #MASLD!
@AASLDtweets @EASLnews @AEEHLiver @sepdigestiva @OWLMetabolomics @CAlonso_OWL

[Rubió Metabolomics @RubioOmics]

Thanks to our outstanding collaborators: @JesusMBanales @MarcoArreseMD @DrJavierCrespo and @NoureddinMD. It is always a pleasure to work with you!

#TLM24 #LiverHealth #MASLD

[Rubió Metabolomics @RubioOmics]

🔬 @OWLMetabolomics is proud to collaborate on a new project targeting #BreastCancer!

Led by Erika Pineda at @UPV, the research uses nanotechnology to destroy tumor cells with precision.

Together, we’re advancing cancer treatment.

#MarieCurie #CancerResearch #Nanomedicine

[Jesus Bañales @JesusMBanales]

20 Years International Research Experience in PSC: What Have We Learn?

👉International Collaborations matters & make the difference
@ipscsg @CcaEns

👉Patient Associations play a central role @PSCPartners @PSCSupportUK

@tomhemmingk at the stage, who better than him! 👏

[Javier Crespo @DrJavierCrespo]

De lectura imprescindible.
Demis Hassabis: Un genio visionario en la intersección de la ciencia y la inteligencia artificial
@MedicineAi @fcarballoa @juliomayol @Buron_ric @jturnesv
https://t.co/hBFY4kKYZV

[Rubió Metabolomics @RubioOmics]

💔 On #WorldCardiacArrestDay, we’re reminded of the importance of accurate #CardiovascularRisk assessment. Traditional tests can miss key risk factors.
🔬 Liposcale®️ provides a deeper analysis of #Lipoprotein particles for better risk prediction.
🚀 Take care of your #Heart!

[Demis Hassabis @demishassabis]

Winning the @NobelPrize is the honour of a lifetime and the realisation of a lifelong dream - it still hasn’t really sunk in yet.

With AlphaFold2 we cracked the 50-year grand challenge of protein structure prediction: predicting the 3D structure of a protein purely from its amino acid sequence. Proteins are the building blocks of life, and knowing the structure of a protein is crucial for understanding the function it performs.

We then folded all 200 million proteins known to science and made those structures freely available for anyone in the world to use, with the help of our wonderful collaborators at @emblebi. Over 2 million researchers have already used AlphaFold2 and its predictions to advance a huge range of important work - everything from enzyme design, to disease understanding, to drug discovery.

But this is only the beginning. Over the next few years AI will help us make great strides towards developing new and more effective therapies for today's most prevalent diseases, and the fantastic team at @IsomorphicLabs are making rapid progress on this mission. I can’t think of a more important or beneficial use of AI.

Then of course there is advancing AGI itself, the original and enduring goal, and the vision behind the founding of DeepMind nearly 15 years ago. If AI is built safely and responsibly, I believe it will be one of the most transformative and beneficial technologies ever. I’ve always thought of AI as the ultimate tool to help us accelerate scientific discovery.

Congratulations to John Jumper (and David Baker!), the amazing AlphaFold team, and all our incredible colleagues at @GoogleDeepMind and @Google that supported and encouraged us along the way - this award is for all of us! It’s been such an honour and privilege to work with all of you to advance the frontiers of AI and science, and there is so much more to come!

[Toni Felís @ToniFs7]

@Nega_Maiz Sense paraules!

[NEGA 🔻 🇵🇸 @Nega_Maiz]

Absolutamente épico e histórico: miembros de The Offspring, Rancid, Bad Religion y Pennywise mientras todos cantan “Bro hymn” en el concierto de despedida de NOFX en San Pedro, California. Decenas de miles de personas.

Se cierra una etapa. Hubiera dado un riñón por estar.